We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, ... Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. Show more
Verrica Pharmaceuticals Inc. Investor Alert (NASDAQ: VRCA): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0274 | 3.18604651163 | 0.86 | 0.94 | 0.7919 | 358899 | 0.87378786 | CS |
4 | -0.6526 | -42.3766233766 | 1.54 | 1.7382 | 0.7043 | 766433 | 0.94953385 | CS |
12 | -1.4426 | -61.9141630901 | 2.33 | 2.52 | 0.7043 | 911667 | 1.48673679 | CS |
26 | -7.7726 | -89.752886836 | 8.66 | 9.395 | 0.7043 | 676446 | 2.61905657 | CS |
52 | -2.8326 | -76.1451612903 | 3.72 | 11.41 | 0.7043 | 665563 | 4.34700301 | CS |
156 | -11.1876 | -92.650931677 | 12.075 | 12.075 | 0.7043 | 366287 | 4.45376371 | CS |
260 | -13.5726 | -93.8630705394 | 14.46 | 18.67 | 0.7043 | 260251 | 5.52427459 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions